Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dawson, Sarah"'
Autor:
Cristofanilli M; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: Massimo.Cristofanilli@nm.org., Pierga JY; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France., Reuben J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rademaker A; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Davis AA; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Peeters DJ; Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium., Fehm T; Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Nolé F; Division of Medical Senology, European Institute of Oncology, Milan, Italy., Gisbert-Criado R; Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain., Mavroudis D; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece., Grisanti S; Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy., Giuliano M; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy., Garcia-Saenz JA; DCIBERONC, IdISCC Madrid, Spain., Stebbing J; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK., Caldas C; Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre, University of Cambridge, Cambridge, UK., Gazzaniga P; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Manso L; Hospital 12 de Octubre, Madrid, Spain., Zamarchi R; Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., de Lascoiti AF; Hospital de Navarra, Pamplona, Spain., De Mattos-Arruda L; Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain., Ignatiadis M; Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Cabel L; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France., van Laere SJ; Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium., Meier-Stiegen F; Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Sandri MT; Division of Laboratory Medicine, Humanitas Reseach Hospital, Rozzano, Milan, Italy., Vidal-Martinez J; Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain., Politaki E; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece., Consoli F; Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy., Generali D; Women Cancer Center, Azienda Socio Sanitaria Territoriale di Cremona, University of Trieste, Italy., Cappelletti MR; Women Cancer Center, Azienda Socio Sanitaria Territoriale di Cremona, University of Trieste, Italy., Diaz-Rubio E; DCIBERONC, IdISCC Madrid, Spain., Krell J; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK., Dawson SJ; Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Raimondi C; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Rutten A; Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium., Janni W; Frauenklinik, University of Ulm, Ulm, Germany., Munzone E; Division of Medical Senology, European Institute of Oncology, Milan, Italy., Carañana V; Clinical Oncology, Hospital Arnau de Vilanova, Valencia, Spain., Agelaki S; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece., Almici C; Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy., Dirix L; Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium., Solomayer EF; Saarland University, Homburg, Germany., Zorzino L; Division of Laboratory Medicine, Humanitas Reseach Hospital, Rozzano, Milan, Italy., Darrigues L; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France., Reis-Filho JS; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Gerratana L; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Medicine, University of Udine, Udine, UD, Italy., Michiels S; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, INSERM U1018, University Paris-Saclay, University Paris-Sud, Villejuif, France., Bidard FC; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France., Pantel K; Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2019 Feb; Vol. 134, pp. 39-45. Date of Electronic Publication: 2018 Dec 19.
Autor:
Salvatore Grisanti, Tanja Fehm, Daniele Generali, Jean-Yves Pierga, Dimitrios Mavroudis, Mario Giuliano, Leticia De Mattos-Arruda, Steven Van Laere, Lorenzo Gerratana, Francesca Consoli, Wolfgang Janni, Klaus Pantel, Luc Dirix, Stefan Michiels, Carlos Caldas, Annemie Rutten, Jorge S. Reis-Filho, Michail Ignatiadis, Dieter Peeters, Andrew M. Davis, Sarah-Jane Dawson, Jose Vidal-Martinez, Cristina Raimondi, Massimo Cristofanilli, Alfred Rademaker, Maria Teresa Sandri, Justin Stebbing, Rita Zamarchi, Franziska Meier-Stiegen, Elisabetta Munzone, Jonathan Krell, Vicente Carañana, Erich-Franz Solomayer, Laura Zorzino, Franco Nolè, Paola Gazzaniga, Eduardo Díaz-Rubio, Lauren Darrigues, Luc Cabel, Rafael Gisbert-Criado, Eleni Politaki, Sofia Agelaki, José A. García-Sáenz, Angela Fernandez de Lascoiti, Maria Rosa Cappelletti, Camillo Almici, Luis Manso, François-Clément Bidard, James M. Reuben
Publikováno v:
Critical reviews in oncology, hematology
Background: The heterogeneity of metastatic breast cancer (MBC) necessitates novel biomarkers allowing stratification of patients for treatment selection and drug development. We propose to use the prognostic utility of circulating tumor cells (CTCs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ef4c527220afcd22fd71cd8f94b62a
https://hdl.handle.net/11368/2935442
https://hdl.handle.net/11368/2935442